ORGANIZATION

Pharma Companies Mull Use of Tohoku University’s Database for Drug Discovery: JPMA Official

December 18, 2018
Drug makers affiliated with the Japan Pharmaceutical Manufacturers Association (JPMA) are mulling the use of the database of the Tohoku University's Tohoku Medical Megabank Organization (ToMMo), with member companies already  starting browsing it on a trial basis “to determine how to use it…

To read the full story

ORGANIZATION

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…